AccueilAccueil>Kamel LAGHMANI est premier auteur d'un article publié dans NEJM

Kamel LAGHMANI est premier auteur d'un article publié dans NEJM

Dans un travail qui vient de paraître en ligne dans l’édition du The New England Journal of Medicine,  Kamel LAGHMANI et son groupe (Equipe "Métabolisme et physiologie rénale", dirigée par Aurélie EDWARDS et Pascal HOUILLIER), en collaboration avec plusieurs équipes internationales, ont contribué à l’identification de mutations dans le gène MAGED2,  responsables d’une forme très sévère mais transitoire du syndrome de Bartter. Cette nouvelle forme du syndrome de Bartter est caractérisée par une perte rénale massive d’eau et de sel, promouvant ainsi une augmentation excessive et précoce du liquide amniotique durant la grossesse, un taux élevé de mortalité périnatale et de naissances prématurées.

 

Polyhydramnios, Transient Antenatal Bartter’s Syndrome, and MAGED2 Mutations

Kamel Laghmani, Bodo B. Beck, Sung-Sen Yang, Elie Seaayfan, Andrea Wenzel, Björn Reusch, Helga Vitzthum, Dario Priem, Sylvie Demaretz, Klasien Bergmann, Leonie K. Duin, Heike Göbel, Christoph Mache, Holger Thiele, Malte P. Bartram, Carlos Dombret, Janine Altmüller, Peter Nürnberg, Thomas Benzing, Elena Levtchenko, Hannsjörg W. Seyberth, Günter Klaus, Gökhan Yigit, Shih-Hua Lin, Albert Timmer, Tom J. de Koning, Sicco A. Scherjon, Karl P. Schlingmann, Mathieu J.M. Bertrand, Markus M. Rinschen, Olivier de Backer, Martin Konrad, Martin Kömhoff


The New England Journal of Medicine, April 27, 2016DOI: 10.1056/NEJMoa1507629


ABSTRACT

BACKGROUND
Three pregnancies with male offspring in one family were complicated by severe polyhydramnios and prematurity. One fetus died; the other two had transient massive salt-wasting and polyuria reminiscent of antenatal Bartter’s syndrome.

METHODS
To uncover the molecular cause of this possibly X-linked disease, we performed wholeexome sequencing of DNA from two members of the index family and targeted gene analysis of other members of this family and of six additional families with affected male fetuses. We also evaluated a series of women with idiopathic polyhydramnios who were pregnant with male fetuses. We performed immunohistochemical analysis, knockdown and overexpression experiments, and protein–protein interaction studies.

RESULTS
We identified a mutation in MAGED2 in each of the 13 infants in our analysis who had transient antenatal Bartter’s syndrome. MAGED2 encodes melanoma-associated antigen D2 (MAGE-D2) and maps to the X chromosome. We also identified two different MAGED2 mutations in two families with idiopathic polyhydramnios. Four patients died perinatally, and 11 survived. The initial presentation was more severe than in known types of antenatal Bartter’s syndrome, as reflected by an earlier onset of polyhydramnios and labor. All symptoms disappeared spontaneously during follow-up in the infants who survived. We showed that MAGE-D2 affects the expression and function of the sodium chloride cotransporters NKCC2 and NCC (key components of salt reabsorption in the distal renal tubule), possibly through adenylate cyclase and cyclic AMP signaling and a cytoplasmic heat-shock protein.

CONCLUSIONS
We found that MAGED2 mutations caused X-linked polyhydramnios with prematurity and a severe but transient form of antenatal Bartter’s syndrome. MAGE-D2 is essential for fetal renal salt reabsorption, amniotic fluid homeostasis, and the maintenance of pregnancy.

 

Full Article:  http://www.nejm.org/doi/pdf/10.1056/NEJMoa1507629

 


Editorial: http://www.nejm.org/doi/pdf/10.1056/NEJMe1603856

 

 

Les Outils